Transcranial Photobiomodulation for Bipolar Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This study the effectiveness and safety of light therapy device targeted at the brain using a wearable device, the Vielight RX Gamma as a treatment for bipolar depression. Up to forty patients with bipolar disorder will be enrolled into the study and will either receive active treatment with the Vielight RX Gamma or sham (inactive device). They will be administered the devices in clinic 5days/week for 6 weeks. Changes in disease symptoms, cognitive function, pain, quality of life and rest EEG changes will be assessed.
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either the active Neuro Rx Gamma device or a sham device in clinic 5 days per week for 6 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Vielight Neuro Rx Gamma
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Treatment with Neuro Rx Gamma
Participants assigned to this arm will be administered the sham device in clinic 5 days per week for 6 weeks
Find a Clinic Near You
Who Is Running the Clinical Trial?
Vielight Inc.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.